Clinical Trials in Minneapolis

Showing 9321-9340 of 14,456 trials

Stem Cell Transplant w/Laronidase for Hurler

NCT00176891

The investigators hypothesize that weekly infusions of Laronidase ERT for 10-12 weeks prior to transplant and 8 weeks following transplant will result in a reduction of glycosaminoglycans (GAG) burden that is associated with decreased complications following transplant.

Mucopolysaccharidosis IHurler Syndrome

Masonic Cancer Center, University of Minnesota25 participantsStarted Mar 2004

Minneapolis, Minnesota, United States

COMPLETED< 1 mile

Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials

NCT01832610

Patients will be approached to participate in this PAS after the HeartWare® Ventricular Assist System receives PMA approval for the indicated use as a bridge to cardiac transplantation.

Heart Failure

Medtronic Cardiac Rhythm and Heart Failure101 participantsStarted Jan 2013

Stanford, California, United States • Washington D.C., District of Columbia, United States • Gainesville, Florida, United States +22 more locations

Stem Cell Transplant w/Laronidase for Hurler

Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials

Find Trials by Condition in Minneapolis

Registry for Integrative Medicine Interventions Effectiveness

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)

Peer Enhanced Prolonged Exposure

Cardiac Monitor Employee Study

Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery

Solace Stress Urinary inContinence Control Efficacy and Safety Study

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

BAY73-4506 Probe Substrate Study

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)